Dr Barbara Guinn

HIKE: Development of a commercial urine test for the earlier detection of endometriosis Jul 1, 2023 - Mar 31, 2025

Endometriosis is a chronic incurable condition that is associated with debilitating pain and subfertility. It affects 190 million women worldwide, takes 8 years to diagnose and costs the UK economy £8.2 billion each year in loss of work (predomi... Read More about HIKE: Development of a commercial urine test for the earlier detection of endometriosis.

Development of a sensitive test for endometriosis Apr 1, 2024 - Mar 31, 2027

Endometriosis and bleeding disorders: detection of endometriosis and identification of new treatment strategies Sep 1, 2024 - Aug 31, 2025
Endometriosis is a chronic, debilitating gynaecological disease that affects 1 in 10 women worldwide. In the UK the average wait for a diagnosis of endometriosis is 8 years which has not improved in over a decade. Due to the lack of an accurate non-... Read More about Endometriosis and bleeding disorders: detection of endometriosis and identification of new treatment strategies.

Funding for Alice Fearn to attend the EACR annual conference Jun 1, 2023 - May 31, 2024
Funding for travel, accommodation and registration the EACR 2023 Congress, Torino, Italy. Poster presentation accepted

Equipment - orbital shaker Aug 1, 2022 - Jul 31, 2023
Endometriosis affects 1 in 10 women worldwide, the same frequency as diabetes but it has had a tiny amount of research funding in comparison. Endometriosis causes debilitating pain that can lead to loss of work, impact mental health and is a major ca... Read More about Equipment - orbital shaker.

Identification of targets for the therapy of epithelial ovarian cancer Mar 1, 2022 - Feb 28, 2023
Finding provided by the INSPIRE grant generously awarded to the Hull York Medical School by the Academy of Medical Sciences through the Wellcome Trust [Ref: IR5\1018]

Effect of preservative on urine analysis Dec 1, 2021 - Nov 30, 2022
I have asked Novosanis whether they would provide consumables money to a MSc by Research students for a project we have discussed this morning (15.10.21). Novosanis want to see the effects of preservatives they are developing on urine samples from pa... Read More about Effect of preservative on urine analysis.

Identification of biomarkers for the earlier detection and targets for the immunotherapy of endometriosis Jan 1, 2022 - Dec 31, 2023
The wait for a diagnosis of endometriosis in the UK has not reduced in a decade. The causes are multifactorial with the non-specific nature of symptoms, waiting lists and the need for invasive laparoscopy contributing to the average 8-year delay to... Read More about Identification of biomarkers for the earlier detection and targets for the immunotherapy of endometriosis.

Development of a cell line that represents early stage ovarian cancer Jan 1, 2022 - Jun 30, 2023
We want to develop an early stage model of OC and determine whether SSX2 is a driver for this disease. To do this we wish to purchase fallopian tube cells that have been immortalised. This process of acquiring fallopian tube cells, immortalising them... Read More about Development of a cell line that represents early stage ovarian cancer.

Characterisation of a urine biomarker for the earlier detection of endometriosis Aug 1, 2021 - Jul 31, 2023
Novosanis intends to provide a research grant of (up to) 25,000€ in support of the most impactful proposal and (up to) 200 Colli-Pee® urine collection devices for use with the project.

Using art to raise awareness of endometriosis Jun 1, 2021 - May 31, 2022
A small charity called Bay Gallery has awarded monies for endometriosis research at the University of Hull/

Article Processing Costs Apr 1, 2021 - Mar 31, 2023
Breaththrough Cancer Reserach has agreed to pay the APC for an article we are publishing based on work that was initiated by funds from them.

Impact of CO2 on antigen expression: new ways to induce immune responses against cancer?’ Jul 1, 2019 - Jun 30, 2020
Summer studentship to investigate the impact of CO2 levels on antigens expression in cancer. The study uses state-of-the-art 3D models to replace whole organism studies of hypoxia.

Dr Barbara Guinn's Projects (13)